188 related articles for article (PubMed ID: 34002950)
1. Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab.
Takamori S; Furubayashi N; Taguchi K; Matsubara T; Fujishita T; Ito K; Yamaguchi M; Toyozawa R; Seto T; Negishi T; Nakamura M; Okamoto T
Thorac Cancer; 2021 Jul; 12(14):2122-2125. PubMed ID: 34002950
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.
Zhao X; Yue D; Qian J; Zhang L; Song J; Zhang B; Zhang C; Sun L; Ma Y; Zhang H; Wang C
Front Immunol; 2022; 13():794217. PubMed ID: 35173719
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma.
Cheshire SC; Board RE; Lewis AR; Gudur LD; Dobson MJ
Radiology; 2018 Nov; 289(2):564-567. PubMed ID: 30106351
[TBL] [Abstract][Full Text] [Related]
5. Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
Kato M; Mori M; Miura K; Asao T; Motomura H; Nishino K; Ko R; Koyama R; Hayashi T; Takahashi K
Thorac Cancer; 2021 Nov; 12(22):3076-3079. PubMed ID: 34617405
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
Sun L; Davis CW; Hwang WT; Jeffries S; Sulyok LF; Marmarelis ME; Singh AP; Berman AT; Feigenberg SJ; Levin W; Ciunci CA; Bauml JM; Cohen RB; Langer CJ; Aggarwal C
Clin Lung Cancer; 2021 Jan; 22(1):58-66.e3. PubMed ID: 33279417
[TBL] [Abstract][Full Text] [Related]
7. Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy.
Okeya K; Kawagishi Y; Muranaka E; Izumida T; Tsuji H; Takeda S
Intern Med; 2019 Nov; 58(22):3295-3298. PubMed ID: 31327828
[TBL] [Abstract][Full Text] [Related]
8. Durvalumab induced sarcoid-like pulmonary lymphadenopathy.
Sanderson E; Wimaleswaran H; Senko C; White S; McDonald CF
Respirol Case Rep; 2020 Apr; 8(3):e00542. PubMed ID: 32110415
[TBL] [Abstract][Full Text] [Related]
9. [Lung cancer with both sarcoid reaction and metastasis in the mediastinal lymph nodes; report of a case].
Fujiwara K; Yasumitsu T; Nakagawa K; Kikui M; Shiono S; Fukuhara K; Takada M
Kyobu Geka; 2003 Dec; 56(13):1144-6. PubMed ID: 14672028
[TBL] [Abstract][Full Text] [Related]
10. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
[TBL] [Abstract][Full Text] [Related]
11. Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature.
Harada K; Ogasawara M; Shido A; Meno A; Oda S; Yoshida S; Yoshida S; Yoshikawa A; Ebata K; Abiko S; Kawagishi N; Sano I; Oda H; Miyagishima T
Thorac Cancer; 2020 May; 11(5):1350-1353. PubMed ID: 32181993
[TBL] [Abstract][Full Text] [Related]
12. [False positive result of 18F-FDG PET in patient with lung cancer due to sarcoid-like reaction in regional lymph nodes].
Kuś E; Gabryś J; Czyżewski D
Pneumonol Alergol Pol; 2014; 82(6):548-54. PubMed ID: 25339565
[TBL] [Abstract][Full Text] [Related]
13. Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.
Levy BP; Giaccone G; Besse B; Felip E; Garassino MC; Domine Gomez M; Garrido P; Piperdi B; Ponce-Aix S; Menezes D; MacBeth KJ; Risueño A; Slepetis R; Wu X; Fandi A; Paz-Ares L
Eur J Cancer; 2019 Feb; 108():120-128. PubMed ID: 30654297
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report.
Matsuoka N; Tsuji K; Ichihara E; Hara T; Fukushima K; Toma K; Kitamura S; Inagaki K; Sugiyama H; Wada J
BMC Nephrol; 2020 Mar; 21(1):113. PubMed ID: 32234009
[TBL] [Abstract][Full Text] [Related]
15. Lung adenocarcinoma initially presenting as Trousseau's syndrome treated successfully with pembrolizumab: A case report.
Nakano Y; Koide N; Koyama Y; Nitta K; Koizumi T
Thorac Cancer; 2021 Feb; 12(4):557-559. PubMed ID: 33350050
[TBL] [Abstract][Full Text] [Related]
16. Surgical results of lung cancer with sarcoid reaction in regional lymph nodes.
Tomimaru Y; Higashiyama M; Okami J; Oda K; Takami K; Kodama K; Tsukamoto Y
Jpn J Clin Oncol; 2007 Feb; 37(2):90-5. PubMed ID: 17272320
[TBL] [Abstract][Full Text] [Related]
17. Hyperprogression after first dose of immunotherapy in a patient with radioresistant metastasis from nonsmall cell lung cancer.
Bosch-Barrera J; Oliva E; Sais E; Vásquez CA; Roselló A; Menéndez JA
Anticancer Drugs; 2019 Nov; 30(10):1067-1070. PubMed ID: 31567311
[TBL] [Abstract][Full Text] [Related]
18. Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab.
Khan AM; Munir A; Thalody V; Munshi MK; Mehdi S
Immunotherapy; 2019 Dec; 11(18):1533-1540. PubMed ID: 31815569
[TBL] [Abstract][Full Text] [Related]
19. Sarcoid reactions in regional lymph nodes of primary lung cancer.
Sugio K; Inoue T; Yokoyama H; Ishida T; Nakano S; Sugimachi K
Respiration; 1993; 60(2):133-6. PubMed ID: 8341856
[TBL] [Abstract][Full Text] [Related]
20. Bilateral lung cancer showing various responses to immune checkpoint inhibitors: A case report.
Kodama H; Ibe T; Inoue R; Shimada T; Ishii H; Hamamoto Y
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1272. PubMed ID: 32783372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
